Dupilumab: Basic aspects and applications to allergic diseases
Author:
Funder
Sanofi
Regeneron
Publisher
Elsevier BV
Subject
General Medicine,Immunology and Allergy
Reference72 articles.
1. Interleukin 4, interleukin 13, and interleukin 9;Izuhara,2011
2. IL-4 and IL-13: their pathological roles in allergic diseases and their potential in developing new therapies;Izuhara;Curr Drug Targets Inflamm Allergy,2002
3. Dupilumab in the management of moderate-to-severe asthma: the data so far;Barranco;Ther Clin Risk Manag,2017
4. Group 2 innate lymphoid cells and asthma;Kabata;Allergol Int,2015
5. T follicular helper and TH2 cells in allergic responses;Kubo;Allergol Int,2017
Cited by 61 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy of Dupilumab in Eosinophilic Esophagitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;American Journal of Therapeutics;2024-01
2. Single-cell RNA sequencing of peripheral blood mononuclear cells from Kimura disease patient successfully treated with dupilumab;Allergology International;2023-10
3. Asthma improvement in patients treated with dupilumab for severe atopic dermatitis;Frontiers in Allergy;2023-09-11
4. Eosinophilic granulomatosis polyangiitis (EGPA) complicated with periaortitis, precipitating role of dupilumab? A case report a review of the literature;RMD Open;2023-09
5. Anti-IL-4/IL-13 antibody (Dupilumab);Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology;2023-08-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3